SmithRx - About the company
SmithRx is a series C company based in San Francisco (United States), founded in 2016. It operates as a Provider of pharmacy benefit management tool for employees. SmithRx has raised $89M in funding from Venrock and Founders Fund, with a current valuation of $*****. The company has 340 active competitors, including 99 funded and 54 that have exited. Its top competitors include companies like Hinge Health, Sharecare and Sword Health.
Company Details
Provider of pharmacy benefit management tool for employees. It improves transparency and is completely auditable. It aims to fight the problem of ever-increasing drug prices.
- Website
- smithrx.com
- Social
- Email ID
- *****@smithrx.com
- Phone Number
- +1 **********
- Registered Address
- San Francisco, California
Key Metrics
Founded Year
2016
Location
San Francisco, United States
Stage
Series C
Total Funding
$89M in 3 rounds
Latest Funding Round
Post Money Valuation
$***** as on Mar 10, 2022
Ranked
32nd among 340 active competitors
Employee Count
613 as on Sep 30, 2026
Investment & Acquisitions
Similar Companies
Legal entities associated with SmithRx
SmithRx is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
SMITH HEALTH, INC. CIN: 811489804 , United States, Active | Feb 07, 2016 | - | 630 (As on Dec 31, 2024) | - |
Sign up to download SmithRx's company profile
SmithRx's funding and investors
SmithRx has raised a total funding of $89M over 3 rounds. Its first funding round was on Jan 11, 2018. Its latest funding round was a Series C round on Nov 15, 2023 for $*****. 1 investor participated in its latest round. SmithRx has 13 institutional investors and 1 angel investor.
Here is the list of recent funding rounds of SmithRx:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 15, 2023 | 9920004 | Series C | 8570294 | 8495959 | 1207475 | 7788393 |
Mar 10, 2022 | 7906879 | Series B | 2837578 | 1916025 | 8539849 | |
Jan 11, 2018 | 2670629 | Series A | 1046218 | 7407487 |
Access funding benchmarks and valuations. Sign up today!View details of SmithRx's funding rounds and investors
SmithRx's founders and board of directors
Founder? Claim ProfileSmithRx's Board of Directors
SmithRx's board has 4 active members. Bryan Roberts, Siobhan Nolan Mangini, Jacob Frenz and Matthew McKnight are independent board members.Here is the list of SmithRx's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 4y 5m | |
mrvctgv | Independent board member | - | Current | 4y 7m |
sbcrnpt | Independent board member | - | Current | 5y 9m |
eekvjal | Independent board member | - | Current | 2y 3m |
SmithRx's employee count trend
SmithRx has 613 employees as of Sep 26. Here is SmithRx's employee count trend over the years:
Uncover SmithRx's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
SmithRx's Competitors and alternates
Top competitors of SmithRx include Hinge Health, Sharecare and Sword Health. Here is the list of Top 10 competitors of SmithRx, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Hinge Health 2015, San Francisco (United States), Public | Provider of virtual physical therapy and digital pain care solutions | $854M | 84/100 | |
2nd | Sharecare 2010, United States, Acquired | Provider of health and wellness social network for employees | $64M | 79/100 | |
3rd |  Sword Health 2015, New York (United States), Series E | Provider of AI-powered digital physical therapy and pelvic health solutions | $450M | 75/100 | |
4th |  Wellhub 2012, New York City (United States), Series F | Cloud based corporate wellness program for employee health, productivity, and retention | $85M | 75/100 | |
5th |  HealthEquity 2002, Draper (United States), Public | Employee benefits management platform for individuals and businesses | $15.3M | 74/100 | |
6th |  Accolade 2007, Plymouth Meeting (United States), Acquired | Cloud-based platform for employee health benefits | $228M | 74/100 | |
7th |  Healthee 2021, New York City (United States), Series B | AI-powered health benefits application for healthcare services | $84M | 73/100 | |
8th | Provider of SaaS based digital platform to manage employee health benefits | $242M | 71/100 | ||
9th | Transcarent 2018, San Francisco (United States), Series D | Provider of employee health benefits solutions | $424M | 70/100 | |
10th | Provider of multiple healthcare services for individuals and organizations | - | - | 70/100 | |
32nd |  SmithRx 2016, San Francisco (United States), Series C | Provider of pharmacy benefit management tool for employees | $89M | 60/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on SmithRx's competitors? Click here to see the top ones
SmithRx's Investments and acquisitions
SmithRx has acquired White Well PBM. SmithRx has not made any investments as of now.Reports related to SmithRx
Here is the latest report on SmithRx's sector:
News related to SmithRx
Filter this listMedia has covered SmithRx for a total of 3 events in the last 1 year, 1 of them has been about company updates and 1 about partnerships.
•
•
SmithRx Awarded Modern Healthcare’s Best in Business for Second Consecutive YearBusiness Wire•Jan 23, 2026•SmithRx
•
UnitedAg Partners with SmithRx to Modernize Pharmacy Benefits at ScaleBusiness Wire•Oct 06, 2025•Unitedag, SmithRx
•
SmithRx saves clients $14.5M with new Stelara biosimilar autoimmune drug.Business Wire•Feb 28, 2025•SmithRx
•
SmithRx Unveils 2024 Growth Momentum, Reducing Pharmacy Benefit Costs by an Average of 30%Business Wire•Feb 12, 2025•SmithRx
•
SmithRx, Modern Healthcare Best of Business, Reaches New Level of Growth and Customer ImpactBusiness Wire•Dec 12, 2024•SmithRx
•
•
SmithRx Introduces New PBM Evaluation Methodology Optimized for Drug Cost SavingsBusiness Wire•Jun 28, 2024•SmithRx
•
SmithRx Raises $60 Million in Series C Funding to Revolutionize Pharmacy Benefits ManagementSilicon Valley Journals•Jan 23, 2024•SmithRx, Venrock, Cost Plus Drug, Amazon
•
SmithRx Teams up With Mark Cuban Cost Plus Drug Company to Reduce Prescription Drug Costs for America’s Patients and EmployersBusiness Wire•Feb 22, 2023•SmithRx, Cost Plus Drug
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about SmithRx
Explore our recently published companies
- Carvarisa - Unfunded company
- Moerke and Sons Pump and Drilling - Chehalis based, 1980 founded, Unfunded company
- Nicolas Abramowicz - Phoenix based, Unfunded company
- Starboard Strategy - Cincinnati based, Unfunded company
- Rocky Mountain Dock and Door Specialties - Littleton based, Unfunded company
- Friend Associates - Unfunded company
